GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.8 at the end of 2024 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...

Nitisinone, a drug for rare diseases, kills mosquitoes when present in human blood and may become a new tool to fight malaria ...

Discover nitisinone, a drug for rare diseases that could also combat mosquitoes and their transmission of malaria.

The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...

The Trump administration intends to terminate the United States’ financial support for Gavi, the organization that has helped purchase critical ...

Mar. 5, 2025 — Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers discovered a key process where malarial parasites take ...

GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...

The difference may be luck, or it may have something to do with the world’s first malaria vaccine. The vaccine has been ...

Gene drive is a new approach to fighting malaria, which involves the creation of a special kind of mosquito “vaccine” that ...

Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former ...

GlaxoSmithKline’s experimental malaria vaccine, RTS,S, has proved only 30% effective when administered to babies, as part of Africa’s largest ever clinical trial. There is a lot of pressure on ...